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Conclusion: In hospital setting, empirical management for
cases of CAP should be based on local bacteriological proﬁle. The
present study has shown K.pneumoniae as the most common
pathogen and cefoperazone-sulbactum as the most likely effec-
tive antimicrobial in hospitalized patients with CAP . Possibility
of Extended spectrum beta lactamase producing klebsiella should
be considered when elderly patients with multiple co- morbidities
admitted with CAP in ICU. Indiscriminate use of carbapenams can
be avoided in these patients, since cefoperazone sulbactum also
caters to the need, leading to better antibiotic stewardship.
http://dx.doi.org/10.1016/j.ijid.2016.02.304
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Background: Cholecystectomy is a clean contaminated surgical
procedure unless infected bile spills into the peritoneum. A single
dose of Cefazolin is recommended for antimicrobial prophylaxis in
high risk patients undergoing cholecystectomy. With drug resis-
tance being common in the community, there is need to formulate
empiric antibiotic policies based on local etiological data .
Methods & Materials: This was a prospective study conducted
fromApril 2015 toMay2015.Gall bladder swabs, bile&pus samples
were accepted as samples and processed for aerobes & for anaer-
obes using conventional media and special media. Identiﬁcation of
aerobes and anaerobes was performed using Vitek cards. The AST
for aerobeswas performed on the Vitek . The antibiotic susceptibil-
ity testing (AST) for anaerobeswasperformedusingE tests. Patients
were classiﬁed on the basis of the different gall bladder pathologies
based on clinical diagnosis, laboratory parameters like total leuko-
cyte counts, C-Reactive protein and radiological investigations like
ultrasound (USG) of the abdomen, Computerised tomography (CT)
abdomen, ERCP/MRCP for common bile duct calculi. They were
also risk stratiﬁed based on previous healthcare contact, antibiotic
exposure, diabetes mellitus and prior invasive procedures.
Results: 91 specimens were processed during the study period.
38(42%) were culture positive. 28(73%) culture positives were
monomicrobial & 10 (27%) were polymicrobial . E.coli & Ente-
rococcus were the predominant gram negative& gram positive
organisms respectively. AST showed 40% ESBLs & 20% Carbapenam
Resistant Organisms. History of previous healthcare contact & con-
sumption of antimicrobial agents were important risk factors for
acquisition of drug resistance. Beta lactam + Betalactamse (BL/BLI)
with or without Aminoglycosides were good empiric options spar-
ing carbapenems. Both gram positive & gram negative organisms
showed < 50% susceptibility to Fluoroquinolones.
Conclusion: Cholecystectomy for asymptomatic cholelithiasis
in a low risk patient performed laproscopically does not require
prophylactic antibiotics. Cefazolin, cefuroxime or Aminoglycosides
maybeuseful as single doseprophylactic agents in lowriskpatients
with other gal bladder pathologies. For high risk patients empiric
therapy should cover for Enterococci and aerobic gram negative
bacilli. Fluoroquinolones have no role to play in empiric therapy
for gall bladder infections.
http://dx.doi.org/10.1016/j.ijid.2016.02.305
Type: Poster Presentation
Final Abstract Number: 41.112
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Missed opportunities for shared decision
making in antimicrobial stewardship: The
potential consequences of a lack of patient
engagement in secondary care
T.M. Rawson1,∗, L.S.P. Moore2, B. Hernandez1, E.
Castro-Sánchez1, E. Charani1, R. Ahmad1, A.H.
Holmes2
1 Imperial College London, London, United Kingdom
2 Imperial College London and Imperial College
Healthcare NHS trust, London, United Kingdom
Background: Within infectious diseases in secondary care,
understandingof thepotential forbehavioural changesarising from
patient involvement in antimicrobial decision making is lacking.
Shared decision making is becoming part of international policy.
The United States have passed it into legislation and the United
Kingdom has implemented a number of national interventions
acrosshealthcarepathways. This studyaims tounderstand the level
of patient involvement in decision making around antimicrobial
use in secondary care and the potential consequences associated
with it.
Methods & Materials: Fourteen members of the public who
had received antimicrobials from secondary care in the preced-
ing 12 months were recruited to participate in group interviews.
Group interactionswere audio-recorded, transcribedverbatim, and
thematically analysed.
Results: Participants reported feelingsofdisempowermentdur-
ing episodes of infection in secondary care. Information is currently
communicated in a unilateral manner with individuals ‘told’ that
they have an infection and will receive an antimicrobial (often
